The Japanese giant will make cost savings of ¥500bn and reduce its workforce by 20,000, and its number of plants from 17 to 10 by FY 2027, after a net loss of ¥670.9bn in FY 2024.

Markets have rallied after a weekend agreement to reduce tariffs to 10% in China and 30% in the US is good news for companies, markets, and the US dollar; however, pharmaceutical stocks are in focus as US president Donald Trump tries to reduce drug prices.

China and the US will start high level trade talks on May 9 in Switzerland.

The agreement, which will reduce tariffs across billions of dollars of goods, comes after three years of talks.

Japan's economy set to be hit amid some wild currency moves across the region, including from the Taiwan dollar.

The SAR's stock exchange is enjoying a boom from Chinese firms looking to expand and tap more investors; the local economy also grew by 3.1% in the first quarter.

A new loan for the Chinese conglomerate included a greenshoe option and involved Chinese and international banks.

The HKMA and CMU OmniClear are leading Hong Kong’s ambitions to internationalise the use of Chinese bonds in global trading. The development of the innovative infrastructure represents a breakthrough for Rmb repos, clearing, settlement and custody.

The Swedish firm has said that it is no longer providing financial guidance for 2025 and 2026, with job losses expected across its global workforce.

While banks should remain conservative, a balance with innovation can be reached, according to Deutsche Bank’s Boon Hiong Chan.